IOGPX
Price
$6.34
Change
+$0.46 (+7.82%)
Updated
Apr 9 closing price
Net Assets
905.38M
NPFCX
Price
$54.57
Change
+$3.98 (+7.87%)
Updated
Apr 9 closing price
Net Assets
122.54B
Ad is loading...

IOGPX vs NPFCX

Header iconIOGPX vs NPFCX Comparison
Open Charts IOGPX vs NPFCXBanner chart's image
Voya Global Insights Portfolio S2
Price$6.34
Change+$0.46 (+7.82%)
VolumeN/A
Net Assets905.38M
American Funds New Perspective C
Price$54.57
Change+$3.98 (+7.87%)
VolumeN/A
Net Assets122.54B
IOGPX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IOGPX vs. NPFCX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOGPX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 123B vs. IOGPX (905M). IOGPX (0.00) and NPFCX (0.00) have matching dividends . IOGPX was incepted earlier than NPFCX: IOGPX (16 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than IOGPX (1.26). IOGPX is a more actively managed with annual turnover of: 107.00 vs. NPFCX (24.00). IOGPX has a lower initial minimum investment than NPFCX: IOGPX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : -10.63 vs. IOGPX (-63.99). NPFCX return over 5 years is better than : 30.30 vs. IOGPX (-59.81).
IOGPXNPFCXIOGPX / NPFCX
Total Expense Ratio1.151.4878%
Annual Report Gross Expense Ratio1.261.4885%
Fund Existence16 years24 years-
Gain YTD-14.161-12.625112%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets905M123B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-63.99-10.63602%
Returns for 3 years-69.72-7.88884%
Returns for 5 years-59.8130.30-197%
Returns for 10 years-68.6634.66-198%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLDD8.810.77
+9.64%
Great Lakes Dredge & Dock Corp
GMAB18.830.85
+4.73%
Genmab A/S ADS
INTR5.260.22
+4.46%
Inter & Co
ALDX1.930.01
+0.78%
Aldeyra Therapeutics
SONN1.25N/A
+0.34%
Sonnet BioTherapeutics Holdings Inc